Liquidia (LQDA) News Today → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free LQDA Stock Alerts $13.12 +0.41 (+3.23%) (As of 11:38 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 19 at 4:34 AM | americanbankingnews.comNeedham & Company LLC Reiterates "Buy" Rating for Liquidia (NASDAQ:LQDA)May 18 at 5:02 AM | americanbankingnews.comFY2024 EPS Estimates for Liquidia Co. (NASDAQ:LQDA) Lowered by AnalystMay 17 at 11:11 AM | seekingalpha.comLiquidia Corp.: A Rich Catalyst Path Lies Ahead For Value UnlockingMay 17 at 8:58 AM | marketbeat.comHC Wainwright Brokers Cut Earnings Estimates for Liquidia Co. (NASDAQ:LQDA)Liquidia Co. (NASDAQ:LQDA - Free Report) - HC Wainwright reduced their FY2024 EPS estimates for Liquidia in a research note issued on Wednesday, May 15th. HC Wainwright analyst A. Fein now forecasts that the company will post earnings per share of ($1.18) for the year, down from their prior estimMay 17 at 6:08 AM | americanbankingnews.comHC Wainwright Reiterates Buy Rating for Liquidia (NASDAQ:LQDA)May 16, 2024 | marketbeat.comLiquidia (NASDAQ:LQDA) Trading Up 5.5%Liquidia (NASDAQ:LQDA) Shares Up 5.5%May 15, 2024 | marketbeat.comLiquidia (NASDAQ:LQDA) Rating Reiterated by HC WainwrightHC Wainwright reaffirmed a "buy" rating and issued a $32.00 price objective on shares of Liquidia in a report on Wednesday.May 15, 2024 | markets.businessinsider.comBullish Outlook for Liquidia Technologies with Buy Rating Amid Anticipated Patent Clarity and Market Growth OpportunitiesMay 15, 2024 | markets.businessinsider.comLiquidia Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)May 15, 2024 | finance.yahoo.comLiquidia Corp (LQDA) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review of ...May 14, 2024 | finance.yahoo.comLiquidia (NASDAQ:LQDA) shareholders have earned a 64% CAGR over the last three yearsMay 14, 2024 | msn.comLiquidia GAAP EPS of -$0.54 misses by $0.24, revenue of $3M misses by $1.39MMay 14, 2024 | msn.comLQDA Stock Earnings: Liquidia Misses EPS, Misses Revenue for Q1 2024May 14, 2024 | marketbeat.comJump Financial LLC Makes New $1.93 Million Investment in Liquidia Co. (NASDAQ:LQDA)Jump Financial LLC acquired a new stake in Liquidia Co. (NASDAQ:LQDA - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 160,641 shares of the company's stock, valued at approximately $1,933,000. Jump Financial LLC owned approximately 0.25%May 13, 2024 | globenewswire.comLiquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate UpdateMay 12, 2024 | americanbankingnews.comLiquidia (LQDA) Scheduled to Post Earnings on TuesdayMay 10, 2024 | globenewswire.comLiquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILDMay 8, 2024 | marketbeat.comLiquidia (LQDA) to Release Quarterly Earnings on TuesdayLiquidia (NASDAQ:LQDA) will be releasing earnings before the market opens on Tuesday, May 14, Zacks reports.May 7, 2024 | finance.yahoo.comLiquidia Corporation to Report First Quarter 2024 Financial Results on May 14, 2024May 7, 2024 | finance.yahoo.comLiquidia Corporation to Present at BofA Securities Health Care Conference 2024May 2, 2024 | marketbeat.comLiquidia Co. (NASDAQ:LQDA) Shares Sold by Strs OhioStrs Ohio decreased its position in Liquidia Co. (NASDAQ:LQDA - Free Report) by 88.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 9,600 shares of the company's stock after selling 70,400 shares durApril 27, 2024 | nasdaq.comCommit To Buy Liquidia Corp At $10, Earn 28% Annualized Using OptionsApril 24, 2024 | insidertrades.comLiquidia Co. (NASDAQ:LQDA) Insider Rajeev Saggar Sells 1,649 SharesApril 23, 2024 | marketbeat.comRajeev Saggar Sells 1,649 Shares of Liquidia Co. (NASDAQ:LQDA) StockLiquidia Co. (NASDAQ:LQDA - Get Free Report) insider Rajeev Saggar sold 1,649 shares of the firm's stock in a transaction that occurred on Friday, April 19th. The shares were sold at an average price of $13.68, for a total transaction of $22,558.32. Following the completion of the sale, the insider now directly owns 211,672 shares of the company's stock, valued at approximately $2,895,672.96. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.April 19, 2024 | insidertrades.comRussell Schundler Sells 2,060 Shares of Liquidia Co. (NASDAQ:LQDA) StockApril 18, 2024 | investing.comLiquidia Corp CEO sells $121,888 in company stockApril 18, 2024 | investing.comLiquidia Corp executive sells shares worth over $23,000April 17, 2024 | marketbeat.comLiquidia Co. (NASDAQ:LQDA) General Counsel Sells $30,034.80 in StockLiquidia Co. (NASDAQ:LQDA - Get Free Report) General Counsel Russell Schundler sold 2,060 shares of Liquidia stock in a transaction that occurred on Friday, April 12th. The shares were sold at an average price of $14.58, for a total transaction of $30,034.80. Following the transaction, the general counsel now owns 486,027 shares of the company's stock, valued at $7,086,273.66. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.April 16, 2024 | insidertrades.comJason Adair Sells 1,189 Shares of Liquidia Co. (NASDAQ:LQDA) StockApril 16, 2024 | marketbeat.comLiquidia Co. (NASDAQ:LQDA) Insider Jason Adair Sells 1,189 SharesLiquidia Co. (NASDAQ:LQDA - Get Free Report) insider Jason Adair sold 1,189 shares of the company's stock in a transaction on Friday, April 12th. The shares were sold at an average price of $14.58, for a total value of $17,335.62. Following the sale, the insider now owns 111,537 shares of the company's stock, valued at approximately $1,626,209.46. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.April 10, 2024 | marketbeat.comLB Partners LLC Invests $3.40 Million in Liquidia Co. (NASDAQ:LQDA)LB Partners LLC bought a new position in Liquidia Co. (NASDAQ:LQDA - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 282,947 shares of the company's stock, valued at approximately $3,404,000. Liquidia comprises 3.7% of LB PartneApril 10, 2024 | marketbeat.comLiquidia's (LQDA) Buy Rating Reaffirmed at Needham & Company LLCNeedham & Company LLC reaffirmed a "buy" rating and set a $28.00 target price on shares of Liquidia in a research note on Wednesday.April 9, 2024 | marketbeat.comLiquidia (NASDAQ:LQDA) Trading Down 2.8%Liquidia (NASDAQ:LQDA) Stock Price Down 2.8%April 3, 2024 | finance.yahoo.comLiquidia Corporation (NASDAQ:LQDA) has caught the attention of institutional investors who hold a sizeable 38% stakeApril 2, 2024 | marketbeat.comLiquidia (NASDAQ:LQDA) Shares Up 2.3%Liquidia (NASDAQ:LQDA) Shares Up 2.3%April 2, 2024 | globenewswire.comLiquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare ConferenceApril 1, 2024 | markets.businessinsider.comBuy Rating Justified by Favorable Legal Outcomes and Imminent FDA Decision for Liquidia Technologies’ YutrepiaApril 1, 2024 | marketbeat.comLiquidia (NASDAQ:LQDA) Shares Gap Up to $14.75Liquidia (NASDAQ:LQDA) Shares Gap Up to $14.75April 1, 2024 | marketbeat.comLiquidia (NASDAQ:LQDA) Receives Buy Rating from Needham & Company LLCNeedham & Company LLC reaffirmed a "buy" rating and issued a $28.00 price objective on shares of Liquidia in a research note on Monday.April 1, 2024 | marketwatch.comLiquidia's Yutrepia Cleared for Potential FDA Approval Following Court RulingApril 1, 2024 | globenewswire.comUpdate on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powderMarch 29, 2024 | bizjournals.comMorrisville firm wins in federal court, targets FDA approvalMarch 28, 2024 | msn.comLiquidia gains after court win in patent dispute with United TherapeuticsMarch 25, 2024 | marketbeat.comLiquidia (NASDAQ:LQDA) Stock Price Down 6.5%Liquidia (NASDAQ:LQDA) Stock Price Down 6.5%March 22, 2024 | marketbeat.comLiquidia (NASDAQ:LQDA) Reaches New 12-Month High at $16.74Liquidia (NASDAQ:LQDA) Hits New 1-Year High at $16.74March 21, 2024 | investing.comLiquidia Corp CMO sells over $119k in company stockMarch 21, 2024 | investing.comLiquidia Corp CEO sells over $450k in company stockMarch 20, 2024 | insidertrades.comJason Adair Sells 4,657 Shares of Liquidia Co. (NASDAQ:LQDA) StockMarch 20, 2024 | insidertrades.comInsider Selling: Liquidia Co. (NASDAQ:LQDA) CEO Sells 28,583 Shares of StockMarch 20, 2024 | finance.yahoo.comInsider Sell: CFO and COO Michael Kaseta Sells 12,166 Shares of Liquidia Corp (LQDA) Get Liquidia News Delivered to You Automatically Sign up to receive the latest news and ratings for LQDA and its competitors with MarketBeat's FREE daily newsletter. Email Address Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow. Click here for your free guide LQDA Media Mentions By Week LQDA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LQDA News Sentiment▼-0.040.42▲Average Medical News Sentiment LQDA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LQDA Articles This Week▼213▲LQDA Articles Average Week Get Liquidia News Delivered to You Automatically Sign up to receive the latest news and ratings for LQDA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Ocular Therapeutix News Today Arcutis Biotherapeutics News Today Centessa Pharmaceuticals News Today OPKO Health News Today 89bio News Today Bicycle Therapeutics News Today Immunome News Today Tyra Biosciences News Today ABIVAX Société Anonyme News Today ARS Pharmaceuticals News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LQDA) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldShocking: One AI startup's revenue could surge 4,735%Manward PressDoes this make you sick?Allegiance GoldCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingBiden Nomination CANCELED?The Freeport SocietyThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Liquidia Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
